DISSINTER

HB 1045 — Maryland

Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

Altering the circumstances under which the Prescription Drug Monitoring Program is required to disclose prescription monitoring data to a federal law enforcement agency to prohibit the disclosure if the Protected Health Care Commission determines that the data is sensitive health services information that has been determined by the Secretary of Health to be legally protected health care.

Latest action: Withdrawn by Sponsor · Mar 3, 2026

WithdrawnCommittees and CommissionsDisclosureDrugsEmergency BillsFederal GovernmentHealthHealth OccupationsLaw EnforcementPrivacyPublic HealthSubpoenas

Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.

Committees: Health (House of Delegates)

Updated Mar 17, 2026

Timeline

  1. First Reading Health

    Feb 9, 2026 · House of Delegates

  2. Hearing 2/26 at 1:00 p.m.

    Feb 13, 2026 · House of Delegates

  3. Hearing canceled

    Feb 24, 2026 · House of Delegates

  4. Withdrawn by Sponsor

    Mar 3, 2026 · House of Delegates

Sponsored by Bonnie Cullison

No recorded floor votes yet.

Fiscal and Policy Note — official analysis by legislative staff (PDF) Bill text (First reading) — Maryland General Assembly (PDF) Official record — Maryland General Assembly bill page

Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (partial import — not yet the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.